Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Scarsbrook

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Physics and Imaging in Radiation Oncology|May 27, 2022
Harmonisation of scanner-dependent contrast variations in magnetic resonance imaging for radiation oncology, using style-blind auto-encodersKavi Fatania, Anna Clark, Russell Frood, et al.
Cancers|February 10, 2024
Prediction of Patient Outcomes in Locally Advanced Cervical Carcinoma Following Chemoradiotherapy-Comparative Effectiveness of Magnetic Resonance Imaging and 2-Deoxy-2-[<sup>18</sup>F]fluoro-D-glucose ImagingSimran Singh Dhesi, Russell Frood, Sarah Swift, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Can Patient Characteristics and Pre-Treatment MRI Features Predict Survival After Stereotactic Ablative Radiotherapy (SABR) Treatment in Hepatocellular Carcinoma (HCC): Preliminary AssessmentRachel Gravell, Russell Frood, Anna Littlejohns, et al.
BMC Cancer|October 6, 2017
Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volumeAndrew Scarsbrook, Gillian Ward, Patrick Murray, et al.
IEEE Journal of Biomedical and Health Informatics|April 6, 2023
Toxicity Prediction in Pelvic Radiotherapy Using Multiple Instance Learning and Cascaded Attention LayersBehnaz Elhaminia, Alexandra Gilbert, John Lilley, et al.
NPJ Precision Oncology|August 31, 2023
Artificial intelligence in ovarian cancer histopathology: a systematic reviewJack Breen, Katie Allen, Kieran Zucker, et al.
European Radiology|August 25, 2022
Utility of pre-treatment FDG PET/CT-derived machine learning models for outcome prediction in classical Hodgkin lymphomaRussell Frood, Matt Clark, Cathy Burton, et al.
The British Journal of Radiology|January 12, 2019
Should we be moving to a national standardized non-gadolinium MR imaging protocol for the surveillance of vestibular schwannomas?Stuart Currie, David Saunders, Jeremy Macmullen-Price, et al.
Lung Cancer (Amsterdam, Netherlands)|August 15, 2015
Authors' response--Risk of malignancy in pulmonary nodules: a validation study of four prediction modelsAli Al-Ameri, Puneet Malhotra, Helene Thygesen, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2015
Risk of malignancy in pulmonary nodules: A validation study of four prediction modelsAli Al-Ameri, Puneet Malhotra, Helene Thygesen, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Physics and Imaging in Radiation Oncology|May 27, 2022
Harmonisation of scanner-dependent contrast variations in magnetic resonance imaging for radiation oncology, using style-blind auto-encodersKavi Fatania, Anna Clark, Russell Frood, et al.
Cancers|February 10, 2024
Prediction of Patient Outcomes in Locally Advanced Cervical Carcinoma Following Chemoradiotherapy-Comparative Effectiveness of Magnetic Resonance Imaging and 2-Deoxy-2-[<sup>18</sup>F]fluoro-D-glucose ImagingSimran Singh Dhesi, Russell Frood, Sarah Swift, et al.
Current Oncology (Toronto, Ont.)|October 25, 2024
Can Patient Characteristics and Pre-Treatment MRI Features Predict Survival After Stereotactic Ablative Radiotherapy (SABR) Treatment in Hepatocellular Carcinoma (HCC): Preliminary AssessmentRachel Gravell, Russell Frood, Anna Littlejohns, et al.
BMC Cancer|October 6, 2017
Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volumeAndrew Scarsbrook, Gillian Ward, Patrick Murray, et al.
IEEE Journal of Biomedical and Health Informatics|April 6, 2023
Toxicity Prediction in Pelvic Radiotherapy Using Multiple Instance Learning and Cascaded Attention LayersBehnaz Elhaminia, Alexandra Gilbert, John Lilley, et al.
NPJ Precision Oncology|August 31, 2023
Artificial intelligence in ovarian cancer histopathology: a systematic reviewJack Breen, Katie Allen, Kieran Zucker, et al.
European Radiology|August 25, 2022
Utility of pre-treatment FDG PET/CT-derived machine learning models for outcome prediction in classical Hodgkin lymphomaRussell Frood, Matt Clark, Cathy Burton, et al.
The British Journal of Radiology|January 12, 2019
Should we be moving to a national standardized non-gadolinium MR imaging protocol for the surveillance of vestibular schwannomas?Stuart Currie, David Saunders, Jeremy Macmullen-Price, et al.
Lung Cancer (Amsterdam, Netherlands)|August 15, 2015
Authors' response--Risk of malignancy in pulmonary nodules: a validation study of four prediction modelsAli Al-Ameri, Puneet Malhotra, Helene Thygesen, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2015
Risk of malignancy in pulmonary nodules: A validation study of four prediction modelsAli Al-Ameri, Puneet Malhotra, Helene Thygesen, et al.
Pageof 7